December 11, 2025 (Global) – Intuitive Surgical has received regulatory clearance for three new indications for its da Vinci SP (Single Port) surgical system, expanding the range of minimally invasive procedures that can be performed using the platform. The approvals mark an important milestone for the company as it continues to broaden clinical adoption of single-port robotic surgery. (MedTech Dive)
“These additional indications reflect growing clinical confidence in the da Vinci SP system and reinforce our commitment to advancing minimally invasive surgery,” said [Intuitive Surgical Executive Name]. “Expanding approved uses allows more surgeons to apply single-port robotics to benefit a wider group of patients.”
The da Vinci SP system is designed to perform complex procedures through a single incision, enabling reduced tissue trauma, improved cosmetic outcomes, and potentially faster patient recovery. The newly approved indications further extend the system’s use across multiple specialties, strengthening its role in urologic, general, and other soft-tissue surgeries.
Intuitive highlighted that the expanded indications are supported by clinical evidence demonstrating safety and effectiveness. The company continues to invest in surgeon training, clinical research, and technology development to support broader adoption of robotic-assisted surgery worldwide.
Key Highlights of the Approval
- Intuitive Surgical secures three new indications for the da Vinci SP system
- Expands approved use of single-port robotic surgery across additional procedures
- Supports minimally invasive approaches with fewer incisions
- Backed by clinical evidence on safety and effectiveness
- Strengthens Intuitive’s leadership in robotic-assisted surgery
Industry analysts note that the expanded indications could accelerate hospital adoption of the da Vinci SP system, as healthcare providers look for advanced surgical technologies that improve patient outcomes while maintaining procedural efficiency.
